Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Company News

The ivWatch Model 400 Now Available to Continuously Monitor IVs

Wednesday, April 06, 2016  
Share |
Medical device manufacturer ivWatch announced the availability of the ivWatch Model 400, a device that continuously monitors a patient’s IV for the early detection of infiltrations – when medication or fluid leaks outside the vein into the surrounding tissue.  Peripheral IVs (PIVs) are one of the most common invasive medical procedures performed with over 150 million IV catheters placed in the U.S. annually.  Yet, current medical reports peg the failure rate of IVs in excess of 20% due to infiltrations.  The ivWatch Model 400 was developed to address this unmet need in health care.  

Complications of PIV infiltration range from pain and redness to severe tissue damage and amputation. To avoid IV failure, clinicians have defaulted to using other, more intrusive vascular access devices. Peripherally inserted central catheters, for example, unfortunately carry other serious risks, such as central-line-associated bloodstream infections, commonly referred to as CLABSIs.

The ivWatch Model 400 represents a new option for medical professionals – a continuously monitored IV – that can allow peripheral IVs to be an appropriate alternative for infusion therapy that can reduce costs, risk, patient harm and medication dosing errors.  The ivWatch Model is the result of more than 16 years of intensive development and clinical testing. The FDA cleared the device for use in 2015.

more Events

10/26/2016 » 10/27/2016
UVA Fall Job & Internship Fair

Premium Members

Membership Software Powered by®  ::  Legal